应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XRTX XORTX Therapeutics Inc.
盘前交易 08-16 05:30:18 EDT
1.49
+0.03
+1.71%
最高
1.54
最低
1.42
成交量
8,162
今开
1.48
昨收
1.47
日振幅
8.19%
总市值
432.63万
流通市值
393.53万
总股本
290.36万
成交额
1.20万
换手率
0.31%
流通股本
264.11万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.12%报1.54美元
自选股智能写手 · 08-15 22:17
Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.12%报1.54美元
Xortx Therapeutics Inc.盘中异动 股价大涨5.76%
自选股智能写手 · 08-13 23:54
Xortx Therapeutics Inc.盘中异动 股价大涨5.76%
Xortx Therapeutics Inc.盘中异动 股价大涨6.67%报1.60美元
自选股智能写手 · 08-09
Xortx Therapeutics Inc.盘中异动 股价大涨6.67%报1.60美元
Xortx Therapeutics Inc.盘中异动 股价大跌8.85%报1.43美元
自选股智能写手 · 08-05
Xortx Therapeutics Inc.盘中异动 股价大跌8.85%报1.43美元
Xortx Therapeutics Inc.盘中异动 大幅下挫6.32%
自选股智能写手 · 08-02
Xortx Therapeutics Inc.盘中异动 大幅下挫6.32%
Xortx Therapeutics Inc.盘中异动 早盘大幅下挫5.00%
自选股智能写手 · 07-30
Xortx Therapeutics Inc.盘中异动 早盘大幅下挫5.00%
Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.13%报1.85美元
自选股智能写手 · 07-25
Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.13%报1.85美元
Xortx Therapeutics Inc.盘中异动 早盘大幅上涨8.00%
自选股智能写手 · 07-24
Xortx Therapeutics Inc.盘中异动 早盘大幅上涨8.00%
Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.00%
自选股智能写手 · 07-23
Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.00%
Xortx Therapeutics Inc.盘中异动 早盘快速拉升11.49%
自选股智能写手 · 07-22
Xortx Therapeutics Inc.盘中异动 早盘快速拉升11.49%
Xortx Therapeutics Inc.盘中异动 早盘快速上涨5.33%
自选股智能写手 · 07-17
Xortx Therapeutics Inc.盘中异动 早盘快速上涨5.33%
Xortx Therapeutics Inc.盘中异动 早盘快速下跌5.03%报1.89美元
自选股智能写手 · 07-16
Xortx Therapeutics Inc.盘中异动 早盘快速下跌5.03%报1.89美元
Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.89%
自选股智能写手 · 07-10
Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.89%
Xortx Therapeutics Inc.盘中异动 早盘股价大跌6.56%
自选股智能写手 · 07-09
Xortx Therapeutics Inc.盘中异动 早盘股价大跌6.56%
Xortx Therapeutics Inc.盘中异动 股价大跌5.78%
自选股智能写手 · 07-03
Xortx Therapeutics Inc.盘中异动 股价大跌5.78%
Xortx Therapeutics Inc.盘中异动 早盘快速拉升9.27%报2.24美元
自选股智能写手 · 06-25
Xortx Therapeutics Inc.盘中异动 早盘快速拉升9.27%报2.24美元
Xortx Therapeutics Inc.股价重挫17.39% 市值跌30.4万美元
自选股智能写手 · 06-20
Xortx Therapeutics Inc.股价重挫17.39% 市值跌30.4万美元
Xortx Therapeutics Inc.盘中异动 早盘股价大跌5.77%报1.96美元
自选股智能写手 · 06-17
Xortx Therapeutics Inc.盘中异动 早盘股价大跌5.77%报1.96美元
Xortx Therapeutics Inc.盘中异动 早盘股价大跌7.14%报1.95美元
自选股智能写手 · 06-14
Xortx Therapeutics Inc.盘中异动 早盘股价大跌7.14%报1.95美元
Xortx Therapeutics Inc.盘中异动 早盘快速下跌8.83%
自选股智能写手 · 06-12
Xortx Therapeutics Inc.盘中异动 早盘快速下跌8.83%
暂无数据
公司概况
公司名称:
XORTX Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立,名称为ReVasCor Inc.在2018年1月10日,公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司,专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法,这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。
发行价格:
--
{"stockData":{"symbol":"XRTX","market":"US","secType":"STK","nameCN":"XORTX Therapeutics Inc.","latestPrice":1.49,"timestamp":1723752000000,"preClose":1.465,"halted":0,"volume":8162,"delay":0,"floatShares":2641137,"shares":2903565,"eps":-1.587782,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.025,"latestTime":"08-16 05:30:18 EDT","open":1.475,"high":1.54,"low":1.42,"amount":11962.605917,"amplitude":0.081911,"askPrice":2,"askSize":100,"bidPrice":0.58,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.587782,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1723815000000},"adr":0,"adjPreClose":1.45,"postHourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.49,"latestTime":"16:00 EDT","volume":1,"amount":1.45,"timestamp":1723752001065},"volumeRatio":0.3542104232030929},"requestUrl":"/m/hq/s/XRTX/tweets","defaultTab":"tweets","newsList":[{"id":"2459475870","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.12%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459475870","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459475870?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:17","pubTimestamp":1723731451,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时17分,Xortx Therapeutics Inc.股票出现异动,股价快速拉升5.12%。截至发稿,该股报1.54美元/股,成交量12股,换手率0.00%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522173197198d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522173197198d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","XRTX"],"gpt_icon":0},{"id":"2459189178","title":"Xortx Therapeutics Inc.盘中异动 股价大涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459189178","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459189178?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:54","pubTimestamp":1723564495,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时54分,Xortx Therapeutics Inc.股票出现波动,股价大幅拉升5.76%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.01%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235455aefea0f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813235455aefea0f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2458344269","title":"Xortx Therapeutics Inc.盘中异动 股价大涨6.67%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458344269","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458344269?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:43","pubTimestamp":1723135384,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时43分,Xortx Therapeutics Inc.股票出现异动,股价快速拉升6.67%。截至发稿,该股报1.60美元/股,成交量705股,换手率0.02%,振幅3.33%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为2.38%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900430496825393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900430496825393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2457790317","title":"Xortx Therapeutics Inc.盘中异动 股价大跌8.85%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457790317","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457790317?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:25","pubTimestamp":1722867947,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日22时25分,Xortx Therapeutics Inc.股票出现异动,股价快速下跌8.85%。截至发稿,该股报1.43美元/股,成交量1038股,换手率0.04%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为3.01%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805222547941fe3b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805222547941fe3b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","XRTX"],"gpt_icon":0},{"id":"2456745287","title":"Xortx Therapeutics Inc.盘中异动 大幅下挫6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456745287","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456745287?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:14","pubTimestamp":1722608086,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时14分,Xortx Therapeutics Inc.股票出现异动,股价快速下挫6.32%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.63%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802221446941fd96c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802221446941fd96c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2455028956","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455028956","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455028956?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:45","pubTimestamp":1722350752,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日22时45分,Xortx Therapeutics Inc.股票出现波动,股价快速跳水5.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.78%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073022455396821a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073022455396821a12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","XRTX","LENZ"],"gpt_icon":0},{"id":"2454799428","title":"Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.13%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454799428","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454799428?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:37","pubTimestamp":1721914628,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时37分,Xortx Therapeutics Inc.股票出现异动,股价快速拉升5.13%。截至发稿,该股报1.85美元/股,成交量53股,换手率0.00%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725213709af941e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725213709af941e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","XRTX"],"gpt_icon":0},{"id":"2453884671","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅上涨8.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453884671","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453884671?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:19","pubTimestamp":1721834385,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时19分,Xortx Therapeutics Inc.股票出现异动,股价大幅上涨8.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.25%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724231945af93ea45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724231945af93ea45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2453105532","title":"Xortx Therapeutics Inc.盘中异动 早盘急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453105532","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453105532?lang=zh_cn&edition=full","pubTime":"2024-07-23 22:33","pubTimestamp":1721745203,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日22时33分,Xortx Therapeutics Inc.股票出现波动,股价大幅上涨5.00%。截至发稿,该股报1.79美元/股,成交量954股,换手率0.03%,振幅5.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.18%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723223323aefb0437&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723223323aefb0437&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2453793601","title":"Xortx Therapeutics Inc.盘中异动 早盘快速拉升11.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453793601","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453793601?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:34","pubTimestamp":1721655254,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时34分,Xortx Therapeutics Inc.股票出现异动,股价急速拉升11.49%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.52%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222134149681ee3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222134149681ee3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2452372157","title":"Xortx Therapeutics Inc.盘中异动 早盘快速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452372157","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452372157?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:39","pubTimestamp":1721223541,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时39分,Xortx Therapeutics Inc.股票出现波动,股价快速上涨5.33%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.76%。其相关个股中,Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.涨幅较大,Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃,换手率分别为793.23%、605.48%、151.32%,振幅较大的相关个股有Aptevo Therapeutics Inc.、4D Molecular Therapeutics, Inc.、Longeveron Inc.,振幅分别为29.37%、21.71%、20.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172139019f5d86a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172139019f5d86a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","XRTX","BK4139"],"gpt_icon":0},{"id":"2451999007","title":"Xortx Therapeutics Inc.盘中异动 早盘快速下跌5.03%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451999007","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451999007?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:47","pubTimestamp":1721137634,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时47分,Xortx Therapeutics Inc.股票出现波动,股价大幅下挫5.03%。截至发稿,该股报1.89美元/股,成交量2021股,换手率0.07%,振幅2.01%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.57%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162147149681d314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162147149681d314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2450816650","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450816650","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450816650?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:28","pubTimestamp":1720621688,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时28分,Xortx Therapeutics Inc.股票出现异动,股价大幅上涨5.89%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.50%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710222809af919ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710222809af919ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2450025813","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大跌6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450025813","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450025813?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:46","pubTimestamp":1720532760,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时46分,Xortx Therapeutics Inc.股票出现波动,股价大幅下跌6.56%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.40%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092146009681b286&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092146009681b286&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","XRTX","LENZ"],"gpt_icon":0},{"id":"2448196341","title":"Xortx Therapeutics Inc.盘中异动 股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448196341","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448196341?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:40","pubTimestamp":1719949259,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时40分,Xortx Therapeutics Inc.股票出现异动,股价快速跳水5.78%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.73%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703034059af903804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703034059af903804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","XRTX","LENZ"],"gpt_icon":0},{"id":"2446411908","title":"Xortx Therapeutics Inc.盘中异动 早盘快速拉升9.27%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446411908","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446411908?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:53","pubTimestamp":1719323634,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时53分,Xortx Therapeutics Inc.股票出现异动,股价快速上涨9.27%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.33%。其相关个股中,Senti Biosciences, Inc.、Glycomimetics, Inc.、康乃德生物涨幅较大,Glycomimetics, Inc.、Effector Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为123.09%、117.86%、76.45%,振幅较大的相关个股有Werewolf Therapeutics, Inc.、Senti Biosciences, Inc.、Glycomimetics, Inc.,振幅分别为29.12%、26.98%、24.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625215354aef6879d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625215354aef6879d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2444451214","title":"Xortx Therapeutics Inc.股价重挫17.39% 市值跌30.4万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444451214","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444451214?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890268,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分,Xortx Therapeutics Inc.股票出现异动,股价急速下挫17.39%。截至发稿,该股报1.90美元/股,成交量154股,换手率0.01%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213108af8e73d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213108af8e73d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","XRTX","BK4007"],"gpt_icon":0},{"id":"2444167685","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大跌5.77%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444167685","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444167685?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:31","pubTimestamp":1718631075,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时31分,Xortx Therapeutics Inc.股票出现波动,股价急速跳水5.77%。截至发稿,该股报1.96美元/股,成交量378股,换手率0.01%,振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.20%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213116aef54923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213116aef54923&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","XRTX","BK4007"],"gpt_icon":0},{"id":"2443671858","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大跌7.14%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443671858","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443671858?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:57","pubTimestamp":1718377020,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时57分,Xortx Therapeutics Inc.股票出现异动,股价急速下挫7.14%。截至发稿,该股报1.95美元/股,成交量1285股,换手率0.04%,振幅0.48%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614225700af8da457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614225700af8da457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","XRTX","LENZ"],"gpt_icon":0},{"id":"2442552275","title":"Xortx Therapeutics Inc.盘中异动 早盘快速下跌8.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552275","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442552275?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:34","pubTimestamp":1718199251,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时34分,Xortx Therapeutics Inc.股票出现异动,股价急速跳水8.83%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.30%。Xortx Therapeutics Inc.公司简介:XORTX Therapeutics Inc 是一家临床阶段的生物技术公司,专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见(孤儿)疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病,以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122134119f352c7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122134119f352c7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","XRTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xortx.com","stockEarnings":[{"period":"1week","weight":-0.0915},{"period":"1month","weight":-0.1768},{"period":"3month","weight":-0.404},{"period":"6month","weight":-0.3318},{"period":"1year","weight":-0.7285},{"period":"ytd","weight":-0.355}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立,名称为ReVasCor Inc.在2018年1月10日,公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司,专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法,这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。","exchange":"NASDAQ","name":"XORTX Therapeutics Inc.","nameEN":"XORTX Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"XORTX Therapeutics Inc.,XRTX,XORTX Therapeutics Inc.股票,XORTX Therapeutics Inc.股票老虎,XORTX Therapeutics Inc.股票老虎国际,XORTX Therapeutics Inc.行情,XORTX Therapeutics Inc.股票行情,XORTX Therapeutics Inc.股价,XORTX Therapeutics Inc.股市,XORTX Therapeutics Inc.股票价格,XORTX Therapeutics Inc.股票交易,XORTX Therapeutics Inc.股票购买,XORTX Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}